FDA Inspection
Terrebonne General Health SystemTerrebonne General Health System – FDA Inspection, Feb 25, 2010
Record Details
This FDA Inspection record concerns Terrebonne General Health System, with an inspection on February 25, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- February 25, 2010
- Product Type
- Biologics
View Company Profile
ID · 76136435-72a7-4f65-bf8b-1beee580a5ca
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 657774
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.100(c)Record review prior to release
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Terrebonne General Health System
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 9, 2025 | Not classified | New Orleans District Office | |
| August 24, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 28, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 10, 2017 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 2, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Terrebonne General Health System
- FDA Inspection 1283764 - 2025-09-09
- FDA Inspection 1217492 - 2023-08-24
- FDA Inspection 1102308 - 2019-08-28
- FDA Inspection 1000028 - 2017-02-10
- FDA Inspection 928625 - 2015-06-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.